 ClearPoint Neuro, Inc. CLPT the Company, a leading platform neurosurgery company, today announced a strategic agreement with PTC Therapeutics, Inc. PTC. The scope of the agreement includes hardware, software, clinical case and market development services for gene therapy cases in the United States and Europe to support PTCs potential commercialization in gene therapy globally upon regulatory approval. 